0001171843-14-002803.txt : 20140624 0001171843-14-002803.hdr.sgml : 20140624 20140612171621 ACCESSION NUMBER: 0001171843-14-002803 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140612 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20140612 DATE AS OF CHANGE: 20140612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL ACTION INDUSTRIES INC CENTRAL INDEX KEY: 0000748270 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 112421849 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-13251 FILM NUMBER: 14907888 BUSINESS ADDRESS: STREET 1: 500 EXPRESSWAY DRIVE SOUTH CITY: BRENTWOOD STATE: NY ZIP: 11717 BUSINESS PHONE: 6312314600 MAIL ADDRESS: STREET 1: 500 EXPRESSWAY DRIVE SOUTH CITY: BRENTWOOD STATE: NY ZIP: 11717 8-K 1 f8k_061214.htm FORM 8-K f8k_061214.htm
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
 
 
FORM 8-K

CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 12, 2014 (June 2, 2014)

 


Medical Action Industries Inc.

(Exact name of registrant as specified in its charter)

 
Delaware
000-13251
11-2421849
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)

 
500 Expressway Drive South
  
Brentwood, New York
11717
(Address of principal executive offices)
(Zip Code)


Registrant’s telephone number, including area code:

(631) 231-4600


Not applicable

(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 
o              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o              Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o              Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o              Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As reported in Medical Action Industries Inc.’s (the “Company”) Current Report on Form 8-K, filed on June 3, 2014, on June 2, 2014 (the “Closing Date”), the Company completed the sale to Medira Inc., (the “Buyer”) a Delaware corporation and an affiliate of Inteplast Group, Ltd. of (i) 100% of the membership units of Medegen Medical Products, LLC, a Delaware limited liability company and a wholly-owned indirect subsidiary of the Company, and (ii) certain assets of the Company’s Patient Care business unit, including the containment business assets (the “Transaction”).
Upon the closing of the Transaction on the Closing Date: (i) Mr. Charles L. Kelly, Jr. resigned as Vice President of the Company and President and General Manager of the Company’s Patient Care business unit and joined the Buyer’s business, effective as of the same date, and (ii) the Company paid Mr. Kelly a transaction bonus in the amount of $150,000 (net of applicable withholding obligations).



 
 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
MEDICAL ACTION INDUSTRIES INC.
       
       
       
  By:
/s/ Brian Baker
  
   
Brian Baker
  
   
Chief Financial Officer
  
       
Dated:    June 12, 2014